Literature DB >> 11890243

Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores.

D J Grossklaus1, C S Coffey, S B Shappell, G S Jack, M S Cookson.   

Abstract

OBJECTIVE: To determine what, if any, additional prognostic information is available from the prostate needle biopsy by comparing the number of biopsy cores obtained with the pathology assessed from the radical retropubic prostatectomy (RRP) specimen. PATIENTS AND METHODS: The results from 135 consecutive patients who underwent RRP at a single institution were reviewed. Needle biopsy information (number of cores, percentage of positive cores, laterality of the positive cores, and Gleason sum) were compared with the pathological data of the RRP specimen, including stage, Gleason sum and tumour volume. Patients were further stratified into those with six or fewer cores (96 men) or more than six cores (39 men). Clinical data, including biopsy information and pathological findings, were compared using univariate and multivariate models.
RESULTS: Overall, univariate analysis showed that the total prostate-specific antigen (PSA) level, number of positive cores, bilateral positive cores and percentage of positive cores were directly correlated with tumour volume (P=0.01). Also, PSA and percentage of positive cores were directly correlated with extracapsular extension (P=0.008 and P=0.01, respectively). In the multivariate model, the most important independent predictors of RRP tumour volume and pathological stage were the preoperative PSA level and percentage of cancer in the biopsy (P<0.01). There was no significant relationship between the number of cores obtained and the predicted pathology of the RRP specimen. There were no differences in the number of positive cores, bilateral positive cores or percentage tumour in the cores between men with more or less than six biopsies. In men with more than six core biopsies, there was no significant increase in prognostic information for tumour volume and extracapsular extension, or a correlation between the Gleason sum on biopsy and the RRP specimen. Taking more than six biopsies did not result in a significantly greater detection of potentially indolent tumours (defined as a tumour volume of <0.5 mL).
CONCLUSIONS: While taking more prostate needle biopsy cores seems to improve the detection of prostate cancer, there appears to be no major improvement in prognostic information over that gained from traditional sextant biopsies. Furthermore, the results suggest that the percentage of positive cores is the best predictor of both pathological stage and tumour volume, from among the information readily available from prostate needle biopsy. Given the variability in the number of cores obtained for diagnosis in clinical practice, these results add credence to the use of the percentage of positive cores in the biopsy set, with known predictors such as PSA and Gleason score, into future models that attempt to predict tumour biology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11890243     DOI: 10.1046/j.1464-4096.2001.02413.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  6 in total

1.  Focal therapy: a new paradigm for the treatment of prostate cancer.

Authors:  Basir Tareen; Guilherme Godoy; Samir S Taneja
Journal:  Rev Urol       Date:  2009

2.  Pathological Correlation between Number of Biopsies and Radical Surgery: Does It Make a Difference to Final Pathology?

Authors:  Tahir Qayyum; Jennifer M Willder; Paul G Horgan; Joanne Edwards; Mark A Underwood
Journal:  Curr Urol       Date:  2013-07-28

3.  Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Prostate Biopsy Significantly Outperforms Systematic 12-Core Biopsy for Prediction of Total Magnetic Resonance Imaging Tumor Volume in Active Surveillance Patients.

Authors:  Chinonyerem Okoro; Arvin K George; M Minhaj Siddiqui; Soroush Rais-Bahrami; Annerleim Walton-Diaz; Nabeel A Shakir; Jason T Rothwax; Dima Raskolnikov; Lambros Stamatakis; Daniel Su; Baris Turkbey; Peter L Choyke; Maria J Merino; Howard L Parnes; Bradford J Wood; Peter A Pinto
Journal:  J Endourol       Date:  2015-07-23       Impact factor: 2.942

4.  Is quadrant biopsy sufficient in men likely to have advanced prostate cancer? Comparison with extended biopsy.

Authors:  Zoran Brnic; Slavko Gasparov; Petar Vladislav Lozo; Petar Anic; Leonardo Patrlj; Vesna Ramljak
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

Review 5.  Saturation biopsies for prostate cancer: current uses and future prospects.

Authors:  Nicolas B Delongchamps; Gabriel P Haas
Journal:  Nat Rev Urol       Date:  2009-11-10       Impact factor: 14.432

6.  Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate.

Authors:  Ernesto Lopez-Corona; Makoto Ohori; Thomas M Wheeler; Victor E Reuter; Peter T Scardino; Michael W Kattan; James A Eastham
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.